Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Herve Mommeja-Marin"'
Autor:
Surya V. Seshan, Ilya G. Glezerman, Genovefa A. Papanicolaou, Gregory E. Chittick, Adam Boruchov, James W. Young, Herve Mommeja-Marin, Yeon Joo Lee
Publikováno v:
American Journal of Kidney Diseases. 65:780-784
Polyomavirus-associated nephropathy (PVAN) is common in patients who have undergone kidney transplantation and has been reported in hematopoietic stem cell (HSC) transplant recipients. Aside from reduction of immunosuppression, few therapeutic option
Publikováno v:
Therapeutic Drug Monitoring
Supplemental Digital Content is Available in the Text.
Background: Brincidofovir (BCV) is an orally bioavailable lipid conjugate of cidofovir (CDV) with increased in vitro potency relative to CDV against all 5 families of double-stranded DNA vir
Background: Brincidofovir (BCV) is an orally bioavailable lipid conjugate of cidofovir (CDV) with increased in vitro potency relative to CDV against all 5 families of double-stranded DNA vir
Autor:
Herve Mommeja-Marin, Francisco M. Marty, Kathlene M. Mullane, Genovefa A. Papanicolaou, Drew J. Winston, Michael Boeckh, Thomas M. Brundage, Tsiporah B. Shore, Roy F. Chemaly, Marion E. Morrison
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(3)
Autor:
Wendy Painter, Michael Neely, Jane Sande, Maggie Anderson, Judith A. Guzman-Cottrill, Steven A. Pergam, Sing Sing Way, Joanne Kurtzberg, Randall Lanier, Joseph Rigdon, Fang Qiu, Diana F. Florescu, Genovefa A. Papanicolaou, Charles van der Horst, Christine Johnston, Herve Mommeja-Marin, M. Graham, Deborah A. Lewinsohn
Publikováno v:
Biology of Blood and Marrow Transplantation. 18(5):731-738
No therapeutic agent has yet been established as the definitive therapy for adenovirus infections. We describe the clinical experience of 13 immunocompromised patients who received CMX001 (hexadecyloxypropyl cidofovir), an orally bioavailable lipid c
Autor:
Herve Mommeja-Marin, Mark N. Prichard, C. Nuss, Richard A. Larson, C.B. Hartline, Jean A. Ridgeway, J. Theusch, Kathleen M. Mullane
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 18(5)
Brincidofovir (BCV) is a broad-spectrum antiviral agent active in vitro against double-stranded DNA viruses including herpesviruses, adenoviruses, polyomaviruses, and poxviruses. We report successful BCV use in management of disseminated acyclovir- a
Autor:
Christian Trepo, M. R. Blum, Herve Mommeja-Marin, Cary Moxham, Seng Gee Lim, Patrick Marcellin, F. Rousseau, Andrea Snow, Hie-Won Hann, Nancy Leung, George K. K. Lau, Jeff Sorbel
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:1282-1292
Summary Background Clevudine is a polymerase inhibitor that has the unusual feature of delayed viral rebound after therapy in some patients which may be related to its pharmacokinetics. Aim To characterize pharmacokinetic and pharmacodynamic profile
Autor:
Gabriela Maron, Herve Mommeja-Marin, Michael Grimley, Eric Bourne, Diana F. Florescu, Thomas M. Brundage, Greg Chittick
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Anita Wong, HY Zhang, George K. K. Lau, Chee-Kin Hui, Nikolai V. Naoumov, Herve Mommeja-Marin, F. Rousseau, Scott Bowden, Nikki P. Lee, Nancy Leung, Stephen Locarnini, Sharon R Lewin, John M. Luk
Publikováno v:
Journal of Clinical Microbiology. 44:2983-2987
The performance characteristics of the RealART and Molecular Beacons assays were compared with those of the Digene Hybrid Capture II assay (ultrasensitive). The results of the RealART and Digene Hybrid assays were related (r = 0.94; P < 0.001) and di
Autor:
Robert G. Gish, Audrey L. Shaw, Herve Mommeja-Marin, Charles Wakeford, Gary Maartens, Michael M. Lederman, Franck Rousseau, John Bartlett, Ian Sanne, Joseph B. Quinn, John Hinkle
Publikováno v:
The Journal of Infectious Diseases. 191:825-829
Human immunodeficiency virus (HIV)-infected South African patients (n=468) received blinded lamivudine or emtricitabine, stavudine, and either nevirapine or efavirenz (based on screening viral load). Baseline characteristics were analyzed in univaria
Autor:
Franck S, Rousseau, Charles, Wakeford, Herve, Mommeja-Marin, Ian, Sanne, Cary, Moxham, Jeanette, Harris, Laura, Hulett, Laurene H, Wang, Joseph B, Quinn, David W, Barry
Publikováno v:
The Journal of Infectious Diseases. 188:1652-1658
We conducted a randomized, open-label, 10-day study that compared the antiretroviral activity of emtricitabine (FTC) 25, 100, and 200 mg once daily and lamivudine (3TC) 150 mg 2 times/day in 82 human immunodeficiency virus (HIV)-infected patients wit